1. Home
  2. ABCL vs LWLG Comparison

ABCL vs LWLG Comparison

Compare ABCL & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$7.87

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

HOLD

Current Price

$9.54

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
LWLG
Founded
2012
1991
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Containers/Packaging
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
ABCL
LWLG
Price
$7.87
$9.54
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$8.40
N/A
AVG Volume (30 Days)
7.1M
5.6M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
15.79
EPS
N/A
N/A
Revenue
$75,128,000.00
$236,855.00
Revenue This Year
N/A
N/A
Revenue Next Year
$21.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
160.56
147.74
52 Week Low
$2.75
$1.26
52 Week High
$8.42
$18.71

Technical Indicators

Market Signals
Indicator
ABCL
LWLG
Relative Strength Index (RSI) 73.27 45.63
Support Level $3.32 $8.83
Resistance Level N/A $10.58
Average True Range (ATR) 0.53 0.78
MACD 0.24 0.02
Stochastic Oscillator 83.58 61.44

Price Performance

Historical Comparison
ABCL
LWLG

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.

Share on Social Networks: